Item Type | Name |
Concept
|
Brain Ischemia
|
Concept
|
Hypoxia-Ischemia, Brain
|
Concept
|
Blood-Brain Barrier
|
Concept
|
Brain
|
Concept
|
Brain Diseases
|
Concept
|
Brain Injuries
|
Concept
|
Natriuretic Peptide, Brain
|
Concept
|
Brain Chemistry
|
Concept
|
Brain Infarction
|
Concept
|
Brain-Derived Neurotrophic Factor
|
Academic Article
|
Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice.
|
Academic Article
|
Modulation of the immune response by POMC-derived peptides. I. Influence on proliferation of human lymphocytes.
|
Academic Article
|
Brain and immune system: a one-way conversation or a genuine dialogue?
|
Academic Article
|
Effects of selective nitric oxide synthase inhibition on IGF-1, caspases and cytokines in a newborn piglet model of perinatal hypoxia-ischaemia.
|
Academic Article
|
Tumor angiogenesis and metastasis formation are associated with individual differences in behavior of inbred Lewis rats.
|
Academic Article
|
Deployment-related severe fatigue with depressive symptoms is associated with increased glucocorticoid binding to peripheral blood mononuclear cells.
|
Academic Article
|
Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration.
|
Academic Article
|
Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain.
|
Academic Article
|
Osteopontin enhances endogenous repair after neonatal hypoxic-ischemic brain injury.
|
Academic Article
|
Longitudinal manganese-enhanced magnetic resonance imaging of delayed brain damage after hypoxic-ischemic injury in the neonatal rat.
|
Academic Article
|
Stem cells in pediatrics: state of the art and future perspectives.
|
Academic Article
|
Differential effects of beta-endorphin on cAMP levels in human peripheral blood mononuclear cells.
|
Academic Article
|
The autonomic nervous system and the immune system in juvenile rheumatoid arthritis.
|
Academic Article
|
Autism and the immune system.
|
Academic Article
|
Dialogue between the brain and the immune system in juvenile chronic arthritis.
|
Academic Article
|
Patients with systemic lupus erythematosus differ from healthy controls in their immunological response to acute psychological stress.
|
Academic Article
|
Who believes in "communication"? The Norman Cousins Lecture, 1999.
|
Academic Article
|
Neonatal glucocorticoids and the developing brain: short-term treatment with life-long consequences?
|
Academic Article
|
Individual differences in behavior of inbred Lewis rats are associated with severity of joint destruction in adjuvant-induced arthritis.
|
Academic Article
|
Expression of nitric oxide synthase isoforms and nitrotyrosine formation after hypoxia-ischemia in the neonatal rat brain.
|
Academic Article
|
Visceral pain and public speaking stress: neuroendocrine and immune cell responses in healthy subjects.
|
Academic Article
|
Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway.
|
Academic Article
|
Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents.
|
Academic Article
|
IL-1 beta signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2.
|
Academic Article
|
Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines.
|
Academic Article
|
G protein-coupled receptor kinase 6 controls post-inflammatory visceral hyperalgesia.
|
Academic Article
|
Alternate pathways preserve tumor necrosis factor-alpha production after nuclear factor-kappaB inhibition in neonatal cerebral hypoxia-ischemia.
|
Academic Article
|
NF-kappaB inhibition after neonatal cerebral hypoxia-ischemia improves long-term motor and cognitive outcome in rats.
|
Academic Article
|
Neuro-immune, behavioral and molecular aspects of brain damage.
|
Academic Article
|
Fatigue, depressive symptoms, and anxiety from adolescence up to young adulthood: a longitudinal study.
|
Academic Article
|
Reduced Th2 cytokine production by sarcoidosis patients in clinical remission with chronic fatigue.
|
Academic Article
|
Predicting PTSD: pre-existing vulnerabilities in glucocorticoid-signaling and implications for preventive interventions.
|
Academic Article
|
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage.
|
Academic Article
|
The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment.
|
Academic Article
|
Exosomes: a new weapon to treat the central nervous system.
|
Academic Article
|
Therapeutic potential of genetically modified mesenchymal stem cells after neonatal hypoxic-ischemic brain damage.
|
Academic Article
|
Neuroinflammation and comorbidity of pain and depression.
|
Academic Article
|
The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies.
|
Academic Article
|
Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury.
|
Academic Article
|
Clinical significance of the neuroendocrine control of autoimmune processes: a important niche for psychoneuroimmunologists?
|
Academic Article
|
Long-term neuroprotection with 2-iminobiotin, an inhibitor of neuronal and inducible nitric oxide synthase, after cerebral hypoxia-ischemia in neonatal rats.
|
Academic Article
|
Social stress and the regulation of tumor necrosis factor-alpha secretion.
|
Academic Article
|
Bilateral molecular changes in a neonatal rat model of unilateral hypoxic-ischemic brain damage.
|
Academic Article
|
Stress, genetics, and immunity.
|
Academic Article
|
Receptor regulation in neuroendocrine-immune communication: current knowledge and future perspectives.
|
Academic Article
|
Heterogeneous medically unexplained symptoms and immune function.
|
Academic Article
|
Low endogenous G-protein-coupled receptor kinase 2 sensitizes the immature brain to hypoxia-ischemia-induced gray and white matter damage.
|
Academic Article
|
Manganese-enhanced magnetic resonance imaging of hypoxic-ischemic brain injury in the neonatal rat.
|
Academic Article
|
Regeneration of the ischemic brain by engineered stem cells: fuelling endogenous repair processes.
|
Academic Article
|
Mild neonatal hypoxia-ischemia induces long-term motor- and cognitive impairments in mice.
|
Academic Article
|
The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury.
|
Academic Article
|
Cell-specific roles of GRK2 in onset and severity of hypoxic-ischemic brain damage in neonatal mice.
|
Academic Article
|
Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function.
|
Academic Article
|
Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage.
|
Academic Article
|
Stimulation of ?2-adrenergic receptors inhibits calcineurin activity in CD4(+) T cells via PKA-AKAP interaction.
|
Academic Article
|
Beneficial effect of erythropoietin on sensorimotor function and white matter after hypoxia-ischemia in neonatal mice.
|
Academic Article
|
Targeting the p53 pathway to protect the neonatal ischemic brain.
|
Academic Article
|
Mesenchymal stem cells as a treatment for neonatal ischemic brain damage.
|
Academic Article
|
Hypothermia and erythropoietin for neuroprotection after neonatal brain damage.
|
Academic Article
|
Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke.
|
Academic Article
|
Cerebral and hepatic inflammatory response after neonatal hypoxia-ischemia in newborn rats.
|
Academic Article
|
Effects of environmental stimuli on immunoreactivity: further studies on passive avoidance behavior.
|
Academic Article
|
Modulation of the immune response by proopiomelanocortin derived peptides. II. Influence of adrenocorticotropic hormone on the rise in intracellular free calcium concentration after T cell activation.
|
Academic Article
|
Ontogency of the responses of human peripheral blood T cells to glucocorticoids.
|
Academic Article
|
Selective inhibition of nuclear factor-kappaB activation after hypoxia/ischemia in neonatal rats is not neuroprotective.
|
Academic Article
|
Gender-dependent pathways of hypoxia-ischemia-induced cell death and neuroprotection in the immature P3 rat.
|
Academic Article
|
The HPA-axis and immune function in burnout.
|
Academic Article
|
A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damage.
|
Academic Article
|
Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia.
|
Academic Article
|
Stem cell therapy for neonatal brain injury: perspectives and challenges.
|
Academic Article
|
Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement.
|
Academic Article
|
Astrocyte GRK2 as a novel regulator of glutamate transport and brain damage.
|
Academic Article
|
Individual behavioral characteristics of wild-type rats predict susceptibility to experimental autoimmune encephalomyelitis.
|
Academic Article
|
Inhibition of nNOS and iNOS following hypoxia-ischaemia improves long-term outcome but does not influence the inflammatory response in the neonatal rat brain.
|
Academic Article
|
Hypoxia/ischemia modulates G protein-coupled receptor kinase 2 and beta-arrestin-1 levels in the neonatal rat brain.
|
Academic Article
|
Stress relief by oxygen?
|
Academic Article
|
Down-regulation of GRK2 after oxygen and glucose deprivation in rat hippocampal slices: role of the PI3-kinase pathway.
|
Academic Article
|
Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder.
|
Academic Article
|
Combination of deferoxamine and erythropoietin: therapy for hypoxia-ischemia-induced brain injury in the neonatal rat?
|
Academic Article
|
Inhibition of the JNK/AP-1 pathway reduces neuronal death and improves behavioral outcome after neonatal hypoxic-ischemic brain injury.
|
Academic Article
|
Microglial GRK2: a novel regulator of transition from acute to chronic pain.
|
Academic Article
|
Mesenchymal stem cells restore cortical rewiring after neonatal ischemia in mice.
|
Academic Article
|
Association between brain natriuretic peptide, markers of inflammation and the objective and subjective response to cardiac resynchronization therapy.
|
Academic Article
|
Intranasal administration of human MSC for ischemic brain injury in the mouse: in vitro and in vivo neuroregenerative functions.
|
Academic Article
|
Neonatal glucocorticoid treatment: long-term effects on the hypothalamus-pituitary-adrenal axis, immune system, and problem behavior in 14-17 year old adolescents.
|
Academic Article
|
Sickness behavior induced by cisplatin chemotherapy and radiotherapy in a murine head and neck cancer model is associated with altered mitochondrial gene expression.
|
Academic Article
|
Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice.
|
Academic Article
|
Sickness behavior induced by cisplatin chemotherapy and radiotherapy in a murine head and neck cancer model is associated with altered mitochondrial gene expression
|
Academic Article
|
Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse
|
Academic Article
|
The seven vells of Immune conditioning
|
Academic Article
|
Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury
|
Academic Article
|
Metformin prevents cisplatin-induced cognitive impairment and brain damage in mice
|
Academic Article
|
Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice
|
Academic Article
|
Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain.
|
Academic Article
|
Pifithrin-? Prevents Cisplatin-Induced Chemobrain by Preserving Neuronal Mitochondrial Function.
|
Academic Article
|
Motivational changes that develop in a mouse model of inflammation-induced depression are independent of indoleamine 2,3 dioxygenase.
|
Academic Article
|
Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling.
|
Academic Article
|
Nasal administration of mesenchymal stem cells restores cisplatin-induced cognitive impairment and brain damage in mice.
|
Academic Article
|
Chemotherapy accelerates age-related development of tauopathy and results in loss of synaptic integrity and cognitive impairment.
|
Academic Article
|
Nasal administration of mesenchymal stem cells reverses chemotherapy-induced peripheral neuropathy in mice.
|
Academic Article
|
An HDAC6 inhibitor reverses chemotherapy-induced mechanical hypersensitivity via an IL-10 and macrophage dependent pathway.
|
Academic Article
|
Chronic restraint stress impairs voluntary wheel running but has no effect on food-motivated behavior in mice.
|
Academic Article
|
Resolution of cisplatin-induced fatigue does not require endogenous interleukin-10 in male mice.
|
Academic Article
|
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy.
|
Academic Article
|
Fibroblast-derived PI16 sustains inflammatory pain via regulation of CD206+ myeloid cells.
|
Academic Article
|
Intranasally Administered MSC-Derived Extracellular Vesicles Reverse Cisplatin-Induced Cognitive Impairment.
|